A revenue channel is not a revenue strategy. Run both.
This page covers two companies rather than one, and the first honest thing to say is why. EnlivenHealth describes itself as a division of Omnicell. Outcomes is a separate company, Outcomes Operating, Inc. We could not verify any corporate relationship between them from either company's public materials, so we treat them as two vendors occupying one category and we assert nothing about their ownership beyond what each states about itself.
Networks and payer relationships an individual pharmacy cannot build alone.
Outcomes pays pharmacies real money through its network
Outcomes publishes that it paid pharmacies $181 million in 2024 and $190 million in 2025 for medication therapy management and clinical services, and describes connecting payers, pharma and providers to what it calls the largest network in pharmacy. Those are their published figures. Whatever your view of the model, that is money arriving at community pharmacies through a channel none of them could have negotiated individually.
Patient engagement built over decades
EnlivenHealth states it is a division of Omnicell serving over 35,000 pharmacies, with outreach coordinated across text, voice, email and mobile, personalized adherence reminders, and inbound calls handled automatically with patients identified and routed with context. Its lineage runs through Ateb, FDS Amplicare and MarkeTouch. Outcomes separately markets automated and patient-driven medication synchronization, cloud-based interactive voice response and two-way messaging.
Clinical opportunity identification, which is genuinely useful
EnlivenHealth describes a workflow where the system finds patients who qualify for clinical services, enables joint booking and electronic documentation, and states that documentation and billing happen in one workflow. Knowing which of your patients is eligible for what is a real capability and it is upstream of everything else.
Established pharmacy footprint
Outcomes owns pharmacy management systems outright, including Rx30, Computer-Rx and TelePharm, and publishes network figures of over 70 million patients and 48,000 pharmacies. If you already run one of their dispensing systems, the integration question is answered before you ask it.
Program participation is a revenue channel. It is not a revenue strategy.
A clinical program network brings you opportunities that already have a payer attached, and that is worth having. What it does not do, and is not designed to do, is tell you whether your business is profitable. It has no view of what your drugs cost, no view of which of your fills adjudicated below that cost, no view of your audit exposure and no view of your purchasing. Those are the questions that determine whether the pharmacy survives the year, and a program that pays you for interventions is orthogonal to all of them. The right relationship here is not competitive. Take the program revenue, and separately know your own numbers. We are the second thing, and nothing about running us interferes with the first.
Complementary, and worth being precise about how.
Figures in the right-hand column are figures these companies publish about themselves. Because these are two separate companies, each cell states which one it refers to where the capability is not common to both.
| Capability | Attergo | EnlivenHealth and Outcomes |
|---|---|---|
| Payer-sponsored clinical program network | No. We do not operate a program network and cannot bring you payer-sponsored opportunities. | Yes. Outcomes publishes $181M in 2024 and $190M in 2025 paid to pharmacies for MTM and clinical services. |
| Patient outreach and adherence communication | No. We are not a patient engagement platform. | Yes. EnlivenHealth coordinates outreach across text, voice, email and mobile with adherence reminders. Outcomes markets IVR and two-way messaging. |
| Medication synchronization | No. | Yes at Outcomes, which markets automated and patient-driven medsync. We found no medsync claim on EnlivenHealth pages and do not attribute it to them. |
| Identifying patients eligible for clinical services | Billable encounters are caught as they happen. We do not prospect your panel for eligibility. | Yes at EnlivenHealth, which states the system finds the patients who qualify for clinical services. |
| Clinical documentation and billing in one workflow | Yes. Encounter to 837P to 835, with documentation checked before submission. | Yes at EnlivenHealth, which states documentation and billing happen in one workflow. |
| Per-fill margin against acquisition cost | Yes, seconds after adjudication, against your own invoice, with the cost source labeled. | Not stated by either company. |
| PBM audit evidence and response packages | Yes, assembled continuously and exported per claim. | Not stated by either company. |
| Purchasing, dead stock and DSCSA | Yes. | Not stated by either company. |
| Owned dispensing systems | None. We integrate with yours and never ask you to change it. | Outcomes owns Rx30, Computer-Rx and TelePharm. EnlivenHealth names no dispensing system integrations publicly. |
Every entry in the EnlivenHealth and Outcomes column is drawn from the pages listed at the foot of this page. Where their own materials do not state a capability, the cell says so rather than guessing, because an absence of marketing copy is not evidence of an absence of capability.
Two honest recommendations.
Choose EnlivenHealth and Outcomes if
you want the program revenue and the patient engagement, which most pharmacies should. Joining a clinical program network is close to free money for work you are positioned to do anyway, and if you already run Rx30 or Computer-Rx the Outcomes relationship is doing useful things for you before you decide anything. Adherence outreach and medication synchronization also lift dispensing volume in a way no analytics product does. Take both, and treat this page as an argument about what to add rather than what to replace.
Choose Attergo if
you have the channel and still cannot answer whether the week made money. Program participation raises revenue; it says nothing about cost, about which fills lost money, about your audit exposure or about your purchasing. Those need a system that holds the claim, the invoice, the encounter and the evidence together, which is what we do, and it sits alongside a program network without touching it.
The product that carries most of this weight on our side is Attergo Intelligence, and it is one of eight on a single connection.
Every claim above traces to their own words.
- EnlivenHealth, Our Story: "EnlivenHealth is a division of Omnicell, Inc.", lineage and pharmacy count
- EnlivenHealth, Patient Solutions: multi-channel outreach, adherence reminders and automated call routing
- EnlivenHealth, Clinical Solution: eligibility identification, joint booking, documentation and billing in one workflow
- Outcomes homepage: medsync, IVR, two-way messaging and the amounts paid to pharmacies in 2024 and 2025
- Outcomes, About Us: Outcomes Operating, Inc. and its constituent brands
- Outcomes press release, 10 July 2023: the TDS and Outcomes combination and Cardinal Health minority stake
What we could not verify
We could not verify any corporate relationship between EnlivenHealth and Outcomes. Outcomes' full press index and about page mention neither EnlivenHealth nor Omnicell, EnlivenHealth's newsroom mentions neither Outcomes nor any ownership change, and Omnicell's investor pages were unreachable. So we state only what each company states about itself and assert no transaction between them. If that is out of date, tell us and we will correct it the same week. Neither company publishes pricing or names specific payers or payer-sponsored programs, and neither names third-party pharmacy management system integrations, so we make no claim on any of those points.
Keep the channel. Add the numbers underneath it.
Thirty minutes, one facility, a read-only connection and credentials you can revoke. We come back with what your own last month actually cost you.
Comparison based on publicly available information as of 2 August 2026. See something outdated? Tell us and we'll fix it. sales@attergo.com